Literature DB >> 16616272

Opioids in the treatment of chronic pain: legal framework and therapeutic indications and limitations.

Donna Bloodworth1.   

Abstract

The most important message that physicians must communicate to persons with chronic pain is that, currently, no medication exists that will take away more than 30% of the pain they experience. Chronic pain is a chronic disease and, like diabetes or hypertension, requires chronic concessions and lifestyle modifications. In controlled trials of short duration and small sample size with highly selected patients, patients sustaining moderate-to-severe pain still experience moderate pain even on opioid medication. Adverse drug effects are predictable and common, and, in fact, long-term compliance with opioids is low owing to side effects. Screening for substance abuse by history taking, observing behavior, obtaining old medical records,and using UDS in patients before initiating opioid therapy is important to identify patients with comorbid addictive disease who require coincident or antecedent treatment. Familiarity with federal and state controlled substance legislation and state health care provider and pain treatment acts is a mundane but essential educational endeavor for all physicians prescribing opioids. If physicians educate their patients with chronic pain about the limited efficacy of the medications, patients' expectations for drug treatment can be more realistic.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16616272     DOI: 10.1016/j.pmr.2005.12.001

Source DB:  PubMed          Journal:  Phys Med Rehabil Clin N Am        ISSN: 1047-9651            Impact factor:   1.784


  4 in total

1.  [Risk minimization in pain therapy: important target but how can it be reached?].

Authors:  G-G Hanekop; F B M Ensink
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

2.  Sustained analgesia achieved through esterase-activated morphine prodrugs complexed with PAMAM dendrimer.

Authors:  Brent B Ward; Baohua Huang; Ankur Desai; Xue-Min Cheng; Mark Vartanian; Hong Zong; Xiangyang Shi; Thommey P Thomas; Alina E Kotlyar; Abraham Van Der Spek; Pascale R Leroueil; James R Baker
Journal:  Pharm Res       Date:  2012-09-28       Impact factor: 4.200

3.  Mindful awareness in body-oriented therapy for female veterans with post-traumatic stress disorder taking prescription analgesics for chronic pain: a feasibility study.

Authors:  Cynthia J Price; Brittney McBride; Lynne Hyerle; Daniel R Kivlahan
Journal:  Altern Ther Health Med       Date:  2007 Nov-Dec       Impact factor: 1.305

4.  Cancer pain management-current status.

Authors:  Deepak Thapa; V Rastogi; Vanita Ahuja
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2011-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.